News and Events

  • A Trio of Biomarkers: A Novel Multivariate Model to Detect DILI & Liver Damage

    Posted: September 27, 2021

    A Trio of Biomarkers: A Novel Multivariate Model to Detect DILI & Liver Damage -Contributed by Abi Kasberg, PhD While maybe underappreciated, Drug-induced liver injury (DILI) is a condition with significant impact on the medical world.  DILI is the leading cause of acute liver failure and is frequently responsible for the termination and withdrawal of…

    Read More

  • ISTH 2021

    Posted: September 27, 2021

    Clot Club – ISTH 2021 David L. McGlasson, MS, MLS(ASCP) Attending the International Society of Thrombosis and Hemostasis 2021 virtually from July 17-21, 2021 was quite a challenge this year.  There were lots of information ranging from clinical, to what I would call “futuristic” research, that we might not see put into clinical practice for…

    Read More

  • Non-Invasive Solutions for Your NASH Clinical Trials

    Posted: September 16, 2021

    It’s Not Just Support. It’s Solutions. Biomarker Assays for NASH Clinical Trials Non-Invasive Biomarkers for Fatty Liver Disease Research The Problem: In early phase NASH trials, performing liver biopsies to evaluate the effect of a potential drug candidate is not always practical or feasible. These relatively short-duration early trials may not result in significant changes…

    Read More

  • Sickle Cell Matters

    Posted: September 10, 2021

    It’s Not Just Support. It’s Solutions. September is National Sickle Cell Awareness Month, a time to acknowledge and educate how this often-invisible and rare disease impacts over 100,000 people in the U.S., most of whom are of African descent. Treatment can include antibiotics, pain management, intravenous fluids, blood transfusion and surgery. Sickle Cell Disease Association…

    Read More

  • Thrombotic Thrombocytopenic Purpura (TTP) Clinical Trials: Targeting the needs left by current treatment options

    Posted: August 19, 2021

    Thrombotic Thrombocytopenic Purpura (TTP) Clinical Trials: Targeting the needs left by current treatment options -Contributed by Abi Kasberg, PhD Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy blood disorder that is characterized by the formation of blood clots in small blood vessels, thrombocytopenia, and a lack of ADAMTS-13 (a disintegrin-like and metalloproteinase with thrombospondin…

    Read More

  • Now available from DiaPharma – CMV Brite™ Turbo Kit for detecting active CMV infection

    Posted: August 18, 2021

    It’s Not Just Support. It’s Solutions. Save Time with CMV Brite™ Turbo Early and rapid diagnosis of active CMV infection is of great importance in avoiding overtreatment with immunosuppressive drugs and in guiding antiviral therapy. The CMV Brite™ Turbo Kit is a rapid immunofluorescence antigenemia kit for in vitro CMV diagnosis. The CMV Brite™ Turbo…

    Read More

  • Distribution Matters: Anti-Human HbS for flow cytometry

    Posted: August 10, 2021

    It’s Not Just Support. It’s Solutions. Anti-Hemoglobin S antibodies from DiaPharma Introducing a new monoclonal antibody for detection of HbS in flow cytometry applications. Now, researchers can accurately measure HbS distribution within a sample, giving additional information on distribution of hemoglobins. This unique antibody offering can be used in conjunction with additional flow cytometry antibodies…

    Read More

  • You Name It, I’ll Do It – The Ceveron® s100

    Posted: August 2, 2021

    It’s Not Just Support. It’s Solutions. Ceveron® s100: Your all-in-one coagulation research analyzer Featuring automated ADAMTS13, Thrombin Generation Testing, FXIII, and full menu of clotting and chromogenic tests Scientists will be excited to learn about the do-it-all Ceveron® s100, for automated hemostasis research assays. You name it, Ceveron® s100 can do it! Featuring Technofluor® ADAMTS13…

    Read More

  • Platelet Party? Let T-TAS® 01 be your designated driver.

    Posted: July 8, 2021

    Platelet Party? Let T-TAS® 01 be your designated driver. Use the leading edge in impaired primary hemostasis assessment and get results quickly with whole blood. The DiaPharma Group is excited to provide Fujimori Kogyo/Zacros’s T-TAS® 01 system – an automated microchip flow chamber system developed for the quantitative assessment of the thrombus formation process under…

    Read More

  • In vitro Liver Culture Systems to Investigate DILI

    Posted: July 8, 2021

    In vitro Liver Culture Systems to Investigate DILI Contributed by Abi Kasberg, PhD An important function of the liver is to concentrate and metabolize drugs and xenobiotics, which makes the liver vulnerable to tissue damage. Drug-induced Liver Injury (DILI) is the onset of liver damage caused by drugs, medications, or supplements. DILI is associated with…

    Read More

  • The Cost Savings of APC Resistance Screening

    Posted: June 23, 2021

    It’s Not Just Support. It’s Solutions. Save with every screening. By screening for Factor V Leiden with the Coatest® APC™ Resistance V kit from DiaPharma, your lab could save thousands of dollars. Each kit was designed to be easy to use for in-house screening, offering fast results and low costs for both large and small…

    Read More

  • Count on DiaPharma for your vWD Research Products

    Posted: June 16, 2021

    It’s Not Just Support. It’s Solutions. Full portfolio of von Willebrand Disease Research Products vWF Activity, Antigen, Collagen Binding, Propeptide, and more. From DiaPharma. Product Spotlight: vWFpp Senova vWF propeptide ELISA* New! Convenient ELISA for research related to vWF clearance mechanisms Rapid double monoclonal ELISA: < 90 min assay time Pre-coated strips make the assay…

    Read More

  • Measure Only ACTIVE Neutrophil Elastase with ProAxsis ELISA

    Posted: June 10, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma is Your Exclusive Source For ProAxsis ProteaseTag™ Active Neutrophil Elastase Assay The Problem Assessing active protease levels in complex biological samples such as sputum or bronchoalveolar lavage samples are problematic due to a lack of reliable and robust methodologies, which result in data with high variability and limited…

    Read More

  • What’s New at DiaPharma? Meet our Pandemic Pets and People

    Posted: May 20, 2021

    It’s Not Just Support. It’s Solutions. Meet the Team We welcomed several new members, 2-legged and 4-legged, to the DiaPharma family during the pandemic! Mary Alice Our Senior Support Scientist, Abi, welcomed daughter Mary Alice into their family last spring, shortly after the start of the pandemic! Mary Alice joins Abi, her husband, their three…

    Read More

  • Hypercoagulation During Sickle Cell Disease

    Posted: May 19, 2021

    Hypercoagulation During Sickle Cell Disease Contributed by Abi Kasberg, PhD Sickle cell disease (SCD) is a genetic hemoglobin disease that disrupts the ability of red blood cells (RBCs) to deliver oxygen throughout the body. RBCs are normally round and flexible, which allows them to flow easily through vasculature. However, in SCD, RBCs are crescent-shaped due…

    Read More

  • Go with the Pro – Intact Proinsulin Assay from DiaPharma

    Posted: May 18, 2021

    It’s Not Just Support. It’s Solutions. Don’t settle when it comes to measuring pancreatic Beta cell function.   Go with the Pro: TECO® Proinsulin ELISA What is Proinsulin? Proinsulin is the precursor of insulin and Connecting Peptide (C-Peptide). Following synthesis, proinsulin is packaged into secretory granules, where it is processed to C-Peptide and insulin by…

    Read More

  • Complement Biomarkers for Alcoholic Liver Disease Research

    Posted: May 17, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma has the tools for your alcoholic liver disease research   Complement Biomarkers for Alcoholic Hepatitis The complement system is a critical component of the immune system that aids in the body’s defense against bacterial and/or viral infections. However, excessive activation of the complement system can result in uncontrolled…

    Read More

  • INRoads to researching liver disease and coagulation

    Posted: April 29, 2021

    It’s Not Just Support. It’s Solutions. DiaPharma has the tools for your Liver Disease Coagulopathy Research   Markers of Hemostasis Liver diseases such as acute fatty liver or cirrhosis can be associated with imbalances in coagulation, whether due to defects of platelet count/function, decrease in synthesis of coagulation factors, decrease in clearance of activated coagulation…

    Read More

  • Now available, Anti-Human HbS (Clone 57-8) for flow cytometry

    Posted: April 29, 2021

    It’s Not Just Support. It’s Solutions. Distribution Matters: Measure Using Flow Cytometry   Anti-Hemoglobin S antibody now available! IQ Products, of the Netherlands, just released a new monoclonal antibody for detection of HbS in flow cytometry applications. Now, researchers can accurately measure HbS distribution within a sample with no overlapping HPLC peaks to allow for…

    Read More

  • Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome – Part 2

    Posted: April 29, 2021

    CLOT CLUB David L. McGlasson, MS, MLS(ASCP) Lupus Anticoagulants/Antiphospholipid Antibodies/Antiphospholipid Antibody Syndrome Part II Testing for Antiphospholipid Antibody Syndrome Platelet-Poor Plasma (PPP) The quality of the patient’s PPP greatly affects the integrity of the testing. To obtain PPP, the capped citrated specimen is centrifuged at room temperature for at least 15 minutes at 1500–2500 Xg.…

    Read More